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Summary 
Platelet-activating factor (PAF) is a potent proinflammatory phosphohpid mediator of the lung. 
In this study, we demonstrate that PAF receptor mRNA and protein is expressed by human 
lung fibroblasts.  Interaction of PAF with its specific receptor resulted in increases of tyrosine 
phosphorylation of several intracellular proteins,  indicating that  the  PAF-receptor might be 
functionally active. PAF-induced transcription ofprotooncogenes c-fos and c-jun as well as of 
interleukin (IL)-6 and IL-8 genes in human fibroblasts.  Transcription of the interleukins was 
followed by secretion of the respective proteins. Moreover, PAF enhanced proliferation of fi- 
broblasts  in  a  concentration-dependent manner.  Using  signaling inhibitors,  we  demonstrate 
that PAF-induced transcription of the c-fos, IL-6, and IL-8 genes, as well as proliferation, re- 
quire activation of pertussis  toxin-sensitive G proteins, tyrosine kinases,  and protein kinase C 
(PKC). In contrast, transcription of c-jun was blocked by pertussis toxin, but not by inhibitors 
for tyrosine kinases or PKC. These data suggest that PAF stimulates distinct signahng pathways 
in human lung fibroblasts.  In addition, the activation of human fibroblasts by PAF leads to en- 
hanced proliferation and to the expression of proinflammatory cytokines, which may contrib- 
ute to the pathophysiological changes in pulmonary inflammation. 
p latelet-activating factor (PAF) 1 is a potent ether-hnked 
phosphohpid mediator that modulates vascular, muscu- 
lar,  and immune function in the human lung (1-5).  Nu- 
merous studies estabhshed an important role of PAF in air- 
way inflammation. Inhalation of PAF provokes asthma-like 
airway responses such as bronchoconstriction, bronchial hy- 
perresponsiveness  (1-3),  increased  vascular  permeability 
(4,  5),  and  mucosal  edema  (4,  5).  Recently,  it  has  been 
shown  that  circulating PAF  is  markedly increased during 
acute asthmatic attacks (3, 6, 7). 
PAF acts via binding to a specific receptor (8-11).  The 
gene coding for the human PAF receptor has been recently 
cloned from leukocytes (8), and has been identified as a sin- 
1Abbreviations used in this paper: PAF, platelet-activating  factor; PKC, pro- 
tein kinase C; PLC, phospholipase  C; ptyr, phosphotyrosine. 
This work was presented  in part at the annual meeting of the American 
Thoracic Society, May 24-25, 1994, Boston, MA, and at the annual 
meeting of the European  Respiratory  Society,  October 1-5, 1994, Nice, 
France. 
gle  copy  gene  on  human  chromosome  1  (12).  Cloning 
studies  of the  PAF  receptor  revealed  that  the  receptor 
shows  homology to G  protein-coupled receptors (8,  12- 
14).  Coupling of the PAF receptor to pertussis  toxin and 
cholera toxin-sensitive G proteins has been reported in hu- 
man  polymorphonuclear leukocytes, B  lymphocytes, and 
platelets  (15,  16).  PAF  activates tyrosine kinases,  as  indi- 
cated by increases in tyrosine phosphorylation of several in- 
tracellular proteins in the same cell types (17,  18).  Further- 
more,  PAF  induces  activation of phospholipase  C  (PLC) 
(18);  it mobilizes cellular calcium from intracellular stores 
(11,  19),  and it increases the  activity of protein kinase  C 
(PKC) (15, 20-22). These PAF-mediated early biochemical 
events are followed by specific gene expression. For exam- 
ple, it has been demonstrated that PAF, via binding to the 
PAF  receptor, promotes rapid induction of c-fos mRNA 
on human B-lymphoblastoid cells (19). In addition, PAF in- 
duces c-fos mRNA expression due to activation of tyrosine 
kinases  and PKC activation in a human carcinoma cell line 
(22). 
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ulating inflammatory responses by enhancing the synthesis 
of certain IL (23-26)  and adhesion molecules (27). Possible 
effects of PAF on lung fibroblasts are of particular interest, 
since  fibroblasts  are  implicated in  the  pathophysiological 
changes of the lung in response to various stimuli (28, 29). 
However, modulatory effects of PAF on gene activation in 
human  fibroblasts  are  still  unknown.  In  this  article,  we 
demonstrate that functional PAF receptors are expressed on 
human lung fibroblasts. The receptor is coupled to G  pro- 
teins, tyrosine kinases, and PKC signaling pathways. More- 
over, activation of these cells by PAF is followed by c-fos, 
c-jun,  IL-6,  and  IL-8  gene  expression  and  proliferation. 
Thus, PAF is shown to have direct and profound biological 
effects  on  human  lung  fibroblasts,  which  could  explain 
some  clinical phenomena  in asthmatics,  such  as leukocyte 
infiltration of the peribronchial tissue and subepithelial fi- 
brosis (30). 
Materials  and Methods 
Generation and  Characterization of Primary Human  Lung  Fibro- 
blasts.  Primary lung fibroblasts cell lines were  generated from 
small pieces (10 mm  2) of sterile lung biopsies (31) obtained from 
patients (n  =  10)  undergoing lung surgery for different reasons. 
Biopsies were taken from parts of the explants that appeared mac- 
roscopically normal. Cells were cultivated in P`PMI 1640 supple- 
mented with r-glutamine (4 rnM; Seromed/Fakola, Basel,  Swit- 
zerland) and 10% FCS (Gibco AG, Basel, Switzerland). 
Immunostaining was performed to define the phenotype of the 
fibroblasts and  to  exclude any contamination with  endothelial, 
epithelial, or smooth muscle cells.  Briefly, cells were grown in 
Lab-Tek tissue culture chamber/slides (Miles, Scientific Division, 
Naperville, IL)  containing eight chambers  (0.9  ￿  0.9  cm)  and 
fixed in  4%  paraformaldehyde.  Cells were  permeabilized with 
0.01%  (wt/vol) Triton X-100 for 10 min (32). To block nonspe- 
cific protein binding,  cells  were  incubated  in  PBS  containing 
0.5% BSA (wt/vol: blocking buffer) for 20 rain. Cells were incu- 
bated for 30 rain with mAb specific to either smooth muscle cell 
actin,  keratin,  Factor VIII, fibronectin, laminin, or von  Wille- 
brand factor (Boehringer Mannheim, Mannheim, Germany). Af- 
ter three washes with blocking buffer, slides were further incu- 
bated for 30  rain with either FITC-coupled anti-rabbit IgG or 
FITC-coupled anti-mouse  IgG  (Boehringer Mannheim).  After 
washing, the preparations were mounted with Fluorosave reagent 
(Calbiochem-Novabiochem, Lucerne, Switzerland) and observed 
on a microscope equipped with epilumination and specific filters 
(560 nm) (Axiophot; Carl Zeiss Inc., Oberkochen, Germany), as 
described earlier (32). 
Identification Of PAF Receptors in Human Lung Fibroblasts.  PAF 
receptor mp`NA was identified by a PCP` technique.  Poly(A)  + 
P`NA was isolated from  107  cultured human lung fibroblasts or 
purified  PBMC  using  an  mp`NA  purification kit  (Pharmacia, 
Dubendorf,  Switzerland). Monocytes were purified by negative 
selection (11). First-strand synthesis and PCR. were carried out as 
previously described (33,  34).  Briefly, fibroblast and  monocyte 
mp`NA, random hexadeoxTnucleotides at 0.2 mg/ml as primers, 
and Moloney murine leukemia virus reverse transcriptase (Phar- 
macia) were used for cDNA synthesis.  PCP, amplification of the 
cDNA encoding the PAF receptor was performed using two 27- 
mer  oligonucleotide primers  corresponding to  sequences  from 
the  initial 18  translated nucleotides  (5'  primer:  5'  GTG  GGA 
TCC ATG GAG CCA CAT GAC TCC 3) and 18 nucleotides 
from the 3' nontranslated region that occur 50 bp after the trans- 
lation stop  codon  (3  primer:  5'  GTG  GAA TCC  ATC  CCT 
TCT TCC  CCC AGC 3'), respectively (13).  [3-Actin oligonu- 
cleotides (Clontech-LucernaChem,  Lucerne,  Switzerland) were 
used to control cDNA synthesis and amplification conditions. For 
amplification, 1 Ixl cDNA was mixed with 2 Ixl of each primer (at 
final  concentration  1  txM),  all  four  deoxynucleotide  triphos- 
phates,  and  Taq  polymerase  (Perkin-Elmer  Cetus,  1Lotkreuz, 
Switzerland) in a reaction buffer containing 1.5 mM Mg  2+. The 
final mixture was incubated for 30 cycles, each cycle consisting of 
1 rain denaturation at 94~  1 min annealing at 45~  and 1 min 
extension at 72~  After amplification, 8 Ixl of PEP- product was 
mn on a 1% agarose gel and transferred to a nitrocellulose mem- 
brane  (Schleicher & Schuell, Dassel,  Germany). The radioactive 
probe was made by random priming, and the membrane was hy- 
bridized with a 32p-labeled probe specific for human PAF recep- 
tor (kind gift from Dr. R.D. Ye, The Scripps p`esearch Institute, 
La Jolla,  CA).  Membranes were  then  washed and autographed 
with intensifying screens at -80~ 
To determine PAF receptor surface expression on human lung 
fibroblasts, cells were harvested by using a cell scraper (Falcon- 
Becton Dickinson, Zurich, Switzerland) and by pipetting force- 
fully. After washing with staining solution (PBS/0.2% heat-inacti- 
vated FCS) cells (10  s) were incubated with polyclonal anti-human 
PAF receptor (11)  or control Ab for 60 min at 4~  Cells were 
then washed twice and incubated with FITC-conjugated, puri- 
fied anti-rabbit IgG Ab (Inotech, Dottikon, Switzerland) for 30 
min at 4~  After washing, cells were analyzed by flow cytometry 
(EPICS-XL; Coulter, Hialeah, FL). 
Detection of Tyrosine Phosphorylation by Immunoblotting.  To dem- 
onstrate that the receptor for PAF is coupled to signaling path- 
ways in fibroblasts, we investigated the level of tyrosine phospho- 
rylation of intracellular proteins. Confluent cultures of cells (2 ￿ 
10 6)  were  stimulated with PAF (10 -s M) for 1,  3,  5,  10, and 30 
min  at  37~  Further steps were  performed  as  previously de- 
scribed (35). Briefly, cell pellets were lysed in SDS-PAGE sample 
buffer (10% SDS, 100 mM Tris [pH 6.8], 1% glycerol, 125 mg/rnl 
bromophenol blue), and then sonicated, 1 mM dithiothreitol was 
added, and samples were boiled for  10 min. Protein concentra- 
tions were determined by the Coomassie blue assay using BSA as 
standard.  Soluble proteins  (100  Izg/sample)  were  separated by 
SDS-PAGE (8%) and transferred onto polyvinylidene difluoride 
membranes (Millipore, Ziirich, Switzerland). Filters were blocked 
in prewarmed blocking buffer (1% BSA, 0.01  M  Tris [pH 7.5], 
0.1 M NaC1,  0.1% Tween 20).  Immunoblots were carried out by 
using an antiphosphotyrosine (ptyr) antibody, P`C20, which was 
peroxidase conjugated (Affiniti,  Nottingham,  U.K.)  at a  1:2500 
dilution with prewarmed blocking buffer for 20 min at 37~  and 
blots were washed extensively in blocking buffer without BSA 
and  developed by  an  enhanced  chemiluminescence  technique 
(ECL  kit; Amersham,  Arlington Heights,  IL)  according to  the 
manufacturer's instructions. 
Detection of mRNA for Protooncogenes and ILs.  Expression of tran- 
scripts for c-fos, c-jun, IL-Rx, IL-113, IL-2, IL-3, IL-4, IL-6, IL-7, 
IL-8, IL-9, and IL-10 was determined using Northern blot analy- 
sis, as described earlier (36). Subconfluent fibroblast cultures were 
serum-deprived for 48 h before being stimulated with PAF (10 -7 
to 10 -1~ M) for various time periods (0, 0.5, 1, 2, 4, 6, 8, and 12 h). 
In further  experiments, various drugs  were  used  to  antagonize 
PAF receptor binding or to inhibit signal transduction pathways 
before PAF stimulation (see below). Total P`NA was  extracted 
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ose  gels  containing 2%  formaldehyde.  RNAs  were  transferred 
onto Hybond nylon membranes (Amersham)  by capillar blotting 
overnight (10￿  SSC: 1.5 M  NaC1,  0.15 M  Na3 citrate,  pH 7.0) 
and cross-linked by UV irradiation.  Membranes were prehybrid- 
ized for 1 h at 45~  with a buffer containing 50% formamide,  1 M 
NaC1,  0.1  SDS,  10% dextran sulfate,  7.5%  polyethylene glycol 
6,000, and 1 mg/ml denatured salmon sperm DNA. Blots were hy- 
bridized overnight with 20 ng of 3' end-labeled ([et-32p]dATP) 
oligonucleotide probes (British Biotechnology, Cowley, U.K.) as 
described (31, 36). Blots were washed twice at room temperature 
with  5￿  SSC  (15  rain each)  and a final wash with  1￿  SSC at 
55~  A  random  prime-labeled  HLA-[3  cDNA  probe  (ATCC 
57474; American Type Culture Collection, Rockville, MD) was 
used as constitutive  control (31, 36). Blots were exposed to Kodak 
X-Omat films overnight or up to 48 h at -80~  Hybridization 
signals were densitometrically analyzed using an automated scan- 
ner system  and the NIH image program from Macintosh.  Cells 
were preincubated for 30 min with 10 ~M of actinomycin D  to 
assess whether elevated  levels of mP,  NAs are caused by increased 
transcription. 
Expression of lL-6 and IL-8 Proteins.  To confirm the data ob- 
tained  at  the  mR.NA level,  we  performed  protein  expression 
studies  for ILs using ELISA techniques.  Cells  were seeded into 
24-well cell culture plates  (Falcon),  cultivated until 80% conflu- 
ence, and brought to quietitude  by incubating cells for 48 h  in 
low serum medium (0.1% FCS). Medium was replaced every 12 h. 
In some experiments,  cells were preincubated with inhibitors  (see 
below) before PAF stimulation (10 -9 M). Aliquots of 100 ~tl cell 
supernatant were collected at 0, 6, 12, and 18 h after the addition 
of PAF.  IL-6 and  IL-8 were  determined by ELISA (Advanced 
Magnetics,  Cambridge, MA) as described (37). 
Inhibition of PAF Receptor Binding and Signal Transduction Path- 
ways.  To demonstrate that the PAF-dependent activation of fi- 
broblasts  is mediated through interaction with its corresponding 
receptor (10), fibroblasts were preincubated in some experiments 
for 30 min with  10  },g/ml to  100  ~g/ml of WEB 2170  (2  X 
10 -s to 2  ￿  10 -4 M), a specific PAF-receptor antagonist  (kindly 
provided by Boehringer Ingelheim, Ingelheim, Germany). 
To  study  the  PAF  receptor-coupled  signaling  pathways  in- 
volved in the transcription  of c-fos and c-jun, and the expression 
of IL-6 and IL-8, subconfluent layers of quiescent fibroblasts were 
stimulated  for various time periods (0, 0.5,  1, 2, 4, 6, 8, and 12 h) 
with different  PAF concentrations (10 -7 to 10 -l~ M) in the pres- 
ence or absence  of specific inhibitors for G proteins, tyrosine ki- 
nase, or PKC. Involvement ofpertussis toxin--sensitive  G proteins 
(15,  16)  in  PAF-dependent  cell  activation was  investigated  by 
preincubating fibroblasts  in the presence of 100  ng/ml pertussis 
toxin (List Biological Laboratories,  Campbell, CA) for 16 h, fol- 
lowed by stimulation with 10 -8 M  PAF. Genistein (100 p~g/ml; 
Sigma Chemical Co., St. Louis, MO) was incubated for 4 h to in- 
hibit tyrosine kinases (38) before stimulation with  10  -s M  PAF. 
To assess whether PKC activation (9,  10, 20,  21)  is required in 
PAF-induced gene expression,  fibroblasts  were preincubated for 
30 min in the presence of 10 mM polymyxin B or 10 mM stauro- 
sporine  (Sigma)  (10). The  same  preincubation  steps  were  per- 
formed to analyze the effect of these inhibitors on PAF-mediated 
IL-6 and IL-8 protein expression. 
PAF-stimulated Proliferation.  The  mitogenic  activity  of PAF 
and the effect  of signal transduction inhibitors were assessed by 
incorporation of [3H]thymidine (Amersham).  Briefly,  fibroblasts 
were seeded  into 48-well cell culture plates  (Falcon)  and grown 
until  80%  confluency. Fibroblast  cultures  were  serum-deprived 
for 48  h  before being stimulated with  10  -l~ to  10 -7 M  PAF. 
Serum-deprived cells were pretreated with signal transduction in- 
hibitors as described  above before being stimulated  with PAF. To 
exclude the possibility  that other growth factors such as IL-6 or 
PDGF-BB are responsible  for PAF-induced cell proliferation,  we 
performed  experiments  using  neutralizing  monoclonal  anti- 
PDGF-BB or anti-IL-6 antibodies  (10 p,g/ml, both from Ik & D). 
18 h after stimulation,  PAFqnduced DNA de novo synthesis was 
assessed by addition  of [3H]thymidine  (0.5  tzCi/ml).  6  h  later, 
[3H]thymidine incorporation was  stopped by washing the  cells 
once with ice-cold PBS and fixation in methanol (twice,  5 min). 
After three washes  with PBS,  acid-soluble  nucleotides were re- 
moved by a single  wash with  0.1  M  trichloric  acid and three 
washes  with  H/O.  Subsequently,  DNA was  resolved in 0.3  M 
NaOH  (15  min),  and  incorporated  [3H]thymidine  was  deter- 
mined by liquid scintillation  counting (39). 
Statistical Analysis.  Means  +  SE for IL proteins were calcu- 
lated on the basis of five  different  fibroblast  cell lines,  and each 
data point was determined in duplicate  in each cell line. Statistical 
analysis  of [3H]thymidine  incorporation  was  performed  using 
Student's paired t test. 
Results 
Characterization of Human Lung Fibroblasts.  Cultures  of 
human lung fibroblasts were established from small lung bi- 
opsies.  First  outgrown  cells  could  be  observed  between 
days 2-6 after setting up the cultures surrounding a piece of 
solid lung tissue.  After the first passage of the primary cell 
cultures  using trypsin-EDTA solution  (0.05:0.02  wt/vol), 
morphological analysis by light microscopy revealed exclu- 
sively  fibroblasts  displaying  a  typical  spindle  shape  mor- 
phology. Fig.  1 presents immunocytochemical characteris- 
tics  of  the  cultured  human  lung  fibroblast  after  three 
passages.  In  our  cell  preparations,  all  spindle-shaped  cells 
stained positive for laminin and fibronectin, but were nega- 
tive for immunostaining with mAbs against smooth muscle 
cell  actin,  keratin,  Factor VIII, or von Willebrand  factor. 
Therefore,  no  contaminations  with  cells  such  as  smooth 
muscle cells,  epithelial  cells,  or endothelial  cells have been 
detected  in  any  of the  cell  cultures  used  for  the  experi- 
ments. 
PAF Receptor mRNA  and  Protein Expression by  Human 
Lung Fibroblasts.  As  shown  in  Fig.  2  a,  PAF  receptor 
mtkNA is  expressed  by human  lung fibroblasts,  as  deter- 
mined by a reversed transcriptase PCR. (RT-PCP,).  Using 
specifc primers corresponding to the sequence of the PAF 
receptor cDNA, a single PCP,. product with the  expected 
size of 1,115 bp was amplified.  Hybridization to a cDNA 
encoding for the human PAl  = receptor confirmed the iden- 
tity  of the  PCR-amplified  fragment  (Fig.  2  a).  Further- 
more, the identity of the PCR fragment to the human PAF 
receptor was demonstrated by sequencing (data not shown). 
To  determine  whether  PAF  receptor  ml~NA  is  also 
translated into protein, we applied a staining technique us- 
ing anti-human PAF receptor antibody, followed by flow- 
cytometric analysis. Human lung fibroblasts were positively 
stained with anti-PAF receptor antibody, as indicated by an 
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cal analysis of cultivated human lung fibroblasts  by immunofluorescence. 
Cells were characterized using mAbs specific  to (a) fibronectin, (b) Iami- 
nin, or (c) von Willebrand factor, followed by F1TC-conjugated second 
antibodies, as described in Materials and Methods. 
increase  of immunofluorescence  compared to  the  control 
antibody (Fig.  2 b). 
PAF Induces Increases in Tyrosine Phosphorylation in Human 
Lung Fibroblasts.  Increases in tyrosine phosphorylation af- 
ter  PAF  stimulation  were  previously  observed  in  several 
cell types (17,  18,  40).  Therefore, the  expression of func- 
tional PAF receptors was assessed by the ability of PAF to 
induce increases in tyrosine phosphorylation ofintracellular 
proteins.  The  addition  of PAF  to  human  lung fibroblasts 
led to rapid increases in tyrosine phosphorylation of several 
intracellular proteins  (Fig.  2  c).  Tyrosine phosphorylation 
increased within 3 rain, peaked at "5  rain, and declined to 
baseline levels within  30  rain  (Fig.  2  c).  Thus,  human fi- 
broblasts express functional  PAF  receptors,  being concor- 
dant with the observed PAF receptor mRNA and protein 
expression data. 
PAF-induced  Gene Expression.  We  determined  PAF- 
induced  expression  of genes  encoding  for  c-fos,  c-jun, 
IL-loL,  IL-113,  IL-2,  IL-3,  IL-4,  IL-5,  IL-6,  IL-7,  IL-8, 
IL-9, and IL-10 in human lung fibroblasts. PAF did not af- 
fect transcription of genes encoding tL-1, IL-2, IL-3, IL-4, 
IL-7, IL-9, and IL-10 in cultivated human lung fibroblasts. 
At concentrations ranging from 10 _7 to  10 -1~ M, PAF was 
capable  of inducing  the  transcription  of the  c-fos,  c-jun, 
IL-6, and IL-8 genes (Fig.  3). The kinetics of PAF-induced 
transcriptional changes were different for each of the  four 
genes.  The  signal  for mlLNA coding for c-fos started  10 
rain after addition of PAF, with a peak at 30 rain, and de- 
clined thereafter.  Maximal amounts of mRNA coding for 
c-jun  were  observed 50-60  rain  after the  addition  of the 
stimulus.  The transcription of the IL-6 gene peaked 1-2 h 
after the addition of PAF and declined thereafter.  Further- 
more, 4-6 h  after the addition of PAF, mkNA  expression 
of IL-8 was  observed.  The  expression of the  constitutive 
control gene (HLA-[3) was not altered by PAF.  Lyso-PAF 
failed to induce gene activation (data not shown). Pretreat- 
ment of fibroblasts with  10  I~M actinomycin D  abolished 
transcription of all four genes, suggesting that the increase 
ofmlLNAs is caused by de novo synthesis and not by accu- 
mulation of the respective mRNAs (data not shown). 
PAF-induced  transcription  of IL-6 and  IL-8 genes  was 
followed by enhanced secretion of the corresponding pro- 
teins into  the  culture medium (Fig.  4).  The PAF-induced 
secretion of both, IL-6 and IL-8, was dose-dependent. Pro- 
tein concentrations of both ILs in the cell culture medium 
were  significantly  enhanced  by  PAF  at  concentrations 
>10 -1~ M  (Fig.  4).  The  stimulatory  effect  of PAF  was 
maximal  at  a  concentration  of  10  -8  M.  Similar  to  the 
mRNA studies, Iyso-PAF did not induce secretion of IL-6 
or IL-8 protein, and PAF-induced secretion of the two ILs 
was inhibited in the presence of actinomycin D. 
PAF Induces Gene Expression  through Binding  to its Specific 
Receptor.  In the presence of the PAF receptor antagonists 
WEB 2170  (2  ￿  10  -5 M), PAF-dependent transcription of 
c-fos, c-jun,  IL-6, and IL-8 was abolished  (Fig.  5).  These 
results  suggest that  PAF-induced  gene  activation is  medi- 
ated through interaction with its specific receptor. 
PAF-induced  Gene Expression Involves at Least  Two Signal- 
ing Pathways.  Analysis of the PAF receptor by cloning (8, 
13,  14) and functional studies (15,  16) revealed that the re- 
ceptor shows  homology to  G  protein-coupled  receptors. 
Therefore,  we  determined the  effect of pertussis toxin on 
PAF-induced  gene  expression.  As  shown  in  Fig.  5,  the 
transcription of c-fos, c-jun,  IL-6, and  IL-8 was abolished 
in the presence ofpertussis toxin. 
As depicted in Fig.  2,  we observed increases in tyrosine 
phosphorylation in  PAF-stimulated human fibroblasts.  To 
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ceptor induces tyrosine phosphorylation in cultivated human pulmonary 
fibroblasts. (a) PAF receptor mP,  NA is expressed in two preparations of 
human pulmonary fibroblasts.  Purified human PBMC were used as posi- 
tive control. Jurkat T cells  were used as negative control (data not shown). 
mRNA expression  was determined by combined PCR.-Southern blotting 
technique, as described in Materials and Methods. Human [3-actin  ampli- 
fication was equal (data not shown). (b) Surface PAF receptor protein ex- 
pression on human pulmonary fibroblasts. Fibroblasts were stained with 
either specific polyclonal anti-PAF receptor antibody or nonspecific rab- 
bit antibody, followed by second-step reagent (FITC-conjugated  anti- 
investigate a possible role for tyrosine kinases in PAF recep- 
tor-mediated gene  activation,  experiments with  the  tyro- 
sine  kinase  inhibitor genistein were  performed.  Northern 
blot analysis revealed that PAF-stimulated transcription of 
c-fos, IL-6, and IL-8 genes was inhibited in the presence of 
genistein. In contrast, c-jun mR.NA expression was not af- 
fected by this compound  (Fig. 5).  Similar results were ob- 
tained using polymyxin B  to inhibit PKC activity (Fig. 5). 
The  data obtained with  mR.NAs  encoding for  IL-6  or 
IL-8 were confirmed at the protein level. As shown in Fig. 6, 
PAF-stimulated secretion of IL-6 and IL-8 was abolished in 
the presence of either one of the signal transduction inhibi- 
tors.  In these experiments, we included a  second PKC in- 
hibitor, staurosporine (10 raM). Both PKC inhibitors, pol- 
ymyxin  B  and  staurosporine,  showed  similar  inhibitory 
effects on the PAF-dependent secretion of IL-6 and IL-8 in 
human lung fibroblasts. Thus,  tyrosine kinase and PKC,  in 
addition to  G  protein  activation,  are  essential for  the  ex- 
pression ofc-fos, IL-6, and IL-8 genes, but not that ofc-jun. 
PAF-induced  Proliferation Depends on  Tyrosine Kinase and 
PKCActivation.  As  demonstrated  in  Fig.  7  a,  PAF  in- 
duced  a  dose-dependent  increase  of de  novo  synthesis of 
DNA  in  cultivated human  lung  fibroblasts. Compared  to 
unstimulated  control cultures,  the  maximal mitogenic  ef- 
fect of PAF was observed at  10 -7 to  10 -8 M  (+61%;  Stu- 
dent's paired t test, P  <0.001);  lyso-PAF, at same concen- 
trations,  did  not  induce  proliferation  (Fig.  7  a).  In  the 
presence of 2-20 IxM PAF receptor antagonist WEB 2170, 
PAF-mediated increase in proliferation was abolished (Stu- 
dent's paired t test, P  <0.005),  while WEB 2170 alone had 
only a minor effect on unstimulated control cells. These data 
further suggest that PAF interacts with its specific receptor 
in human fibroblasts. Moreover, incorporation of [3H]thy- 
midine was inhibited after pretreatment of fibroblasts with 
either genistein (P <0.01), pertussis toxin (P <0.01), or the 
PKC  inhibitors staurosporine  (P  <0.05)  or polymyxin B 
(P <0.01),  while the compounds did not significantly alter 
spontaneous  incorporation  of [3H]thymidine  in  unstimu- 
lated control cells (Fig. 7 b). Thus, similar to the c-fos, IL-6, 
and IL-8 gene expression data, tyrosine kinase and PKC ac- 
tivation is required, in addition to G  protein activation, for 
PAF-induced proliferation. 
To exclude the possiblity that the mitogenic effect of PAF 
is mediated by other growth factors such as PDGF  (31)  or 
IL-6  (37),  we  performed  experiments  in  the  presence  of 
neutralizing monoclonal anti-PDGF-BB or anti-IL-6 anti- 
bodies. As depicted in Fig. 7  c,  the neutralizing antibodies 
had no significant inhibitory effect in this system, suggest- 
ing  that  PAF-induced proliferation of human  pulmonary 
rabbit Ab). This figure is representative of two  other  experiments that 
yielded the same results. (c) PAF induces tyrosine phosphorylation of sev- 
eral cellular substrates in human pulmonary fibroblasts. Fibroblasts were 
stimulated with 10  -7 M PAF for the indicated times. Tyrosine phospho- 
rylation was determined by immunoblotting using an anti-ptyr antibody. 
Units are in kilodaltons. 
195  P,  oth et al. receptor. Furthermore, we have demonstrated the functional 
integrity of the  PAF receptor and its  coupling to pertussis 
toxin-sensitive  G  proteins,  tyrosine  kinases,  and  PKC  in 
these  cells.  Moreover,  PAF  induced  the  transcription  of 
genes encoding c-fos, c-jun, IL-6, and IL-8, and stimulated 
the  proliferation  of lung fibroblasts.  The  specificity  of re- 
ceptor-ligand  interaction  was  confirmed  using  a  PAF  re- 
ceptor antagonist, WEB 2170. In the presence of this com- 
pound, PAF receptor-mediated signaling, gene expression, 
and  proliferation  were  inhibited.  The  specificity  was  fur- 
ther confirmed by the fact that lyso-PAF, a biological inef- 
fective PAF  analogue,  did not exert  any effect on  human 
lung fibroblasts. 
PAF stimulates  tyrosine kinases as monitored by tyrosine 
phosphorylated proteins in human neutrophils  (17), mono- 
Figure  3.  PAF induces gene transcription in fibroblasts. Kinetics of 
PAF-induced (10  -8 M) gene transcription in cultivated human pulmo- 
nary fibroblasts by Northern blot analysis. The picture displays a charac- 
teristic time course in cell line L032; similar results were obtained with 
the nine other cell lines. 
fibroblasts  is  not  a  consequence  of PAF-induced  growth 
factor mobilisation. 
Discussion 
PAF  has  been  implicated  in  the  pathogenesis  of airway 
inflammation and mucus hypersecretion  (1-3,  30,  41-44). 
Especially in pathophysiological events associated with asthma, 
PAF apparently plays a crucial role (42). For example, it has 
been demonstrated that circulating PAF levels are increased 
during  acute  asthmatic  attacks  (2,  6,  7).  An enhanced  re- 
lease of PAF from granulocytes isolated from asthmatic pa- 
tients has been reported (6, 7). In addition, platelets isolated 
from asthmatic  individuals  displayed  an  enhanced  respon- 
siveness  to  exogenous  PAF  (45-47).  Furthermore,  an  in- 
creased  expression  of PAF  receptor  mR.NA  in  asthmatic 
lung  tissue  has  been  observed  (3,  9,  43,  48).  Since  fibro- 
blasts represent  a large portion of solid lung tissue  and are 
situated  adjacent  to both  airways  and  blood vessels,  these 
cells  are likely to participate in inflammatory processes and 
remodelling of the lung (23, 28, 29). However, direct stim- 
ulatory  action  of PAF  on  human  lung  fibroblasts  has  not 
yet been  demonstrated.  Therefore,  we  characterized  PAF 
receptor gene expression,  signal transduction pathways, the 
induction of protooncogenes and IL genes, as well as func- 
tional consequences of PAF receptor stimulation,  in human 
lung fibroblasts. 
Our results  provide  several lines  of evidence  for an in- 
volvement of fibroblasts in PAF-induced inflammatory re- 
sponses of the lung.  Using P,T-PCR. and flow cytometry, 
we have shown that cultivated lung fibroblasts express PAF 
receptor mP,  NA and protein  for the  recendy cloned PAF 
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Figure 4.  PAF induces secretion of IL-6 and IL-8 from fibroblasts. Ki- 
netics of PAF-induced (10  -s M) secretion oflL-6 (a) and IL-8 (b) in cul- 
tivated human pulmonary fibroblasts. The amount of  secreted interleukins 
was determined in 100 ILl of culture medium obtained from subconfluent 
cultures of pulmonary fibroblasts (10  s cell). Each data point represents 
mean + SE of  30 independent experiments using 10 different cell lines. 
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(22).  Therefore,  we  investigated  whether  stimulation  of 
lung fibroblasts with PAF also results in tyrosine kinase ac- 
tivation. Indeed, PAF stimulated the tyrosine phosphoryla- 
tion of several intracellular proteins. This suggests  that the 
PAF receptor expressed on human lung fibroblasts is cou- 
pled to tyrosine kinases. 
A central question is how the PAF receptor, which rep- 
resents a member of the G  protein-linked receptor super- 
family (8, 9, 13,  15,  16, 40, 46), could activate one or more 
tyrosine kinases.  We confirmed the linkage of the PAF re- 
ceptor to  G  proteins  since  pertussis  toxin blocked  PAF- 
induced  gene  expression and  proliferation. This  indicates 
that  direct  activation  of tyrosine  kinases  by  the  ligand- 
bound receptor and bypassing of G proteins may not occur 
in these cells.  However, tyrosine kinases  may be activated 
via a pertussis-sensitive G protein (40,  47). Our strategy to 
determine  the  relevance  of tyrosine  kinase  activation  in 
PAF-induced fibroblast activation was  to  use the  tyrosine 
kinase inhibitor genistein in our systems. Genistein is known 
to specifically inhibit the activity of tyrosine kinases, whereas 
it  has  marginal  effects  on  several  serine/threonine  kinases 
(38). The finding that genistein and PKC inhibitors blocked 
PAF-induced  proliferation and  expression of c-fos,  IL-6, 
and IL-8, but not of c-jun, suggests  a functional important 
signaling pathway involving the  activation of G  proteins, 
tyrosine kinases,  and PKC. In contrast, PAF-induced tran- 
scription of c-jun is  only sensitive  to  pertussis  toxin, but 
not to  genistein or polymyxin B, indicating the existence 
of a PAF-inducible signaling pathway, which bypasses  ty- 
rosine kinases  and PKC activation in human fibroblasts. 
We have shown a rapid and transient transcriptional acti- 
vation of c-fos and c-jun by PAF, as assessed by Northern 
blot analysis. The kinetics of the PAF-induced transcription 
of both  transcription  factors  are  similar  to  that  observed 
with other mitogens such as angiotensin II  (32)  or PDGF 
isoforms (36).  PAF-induced expression of both genes sug- 
gests  that  this  phospholipid  is  a  potent  regulator  of cell 
growth and differentiation. The protooncogenes c-fos and 
c-jun are members of the  class of inducible genes termed 
cellular immediate early genes (48).  Both protooncogenes 
encode proteins that are capable of forming a protein com- 
plex (AP-1) that binds specifically to transcriptional control 
elements (49).  The fact that PAF is capable of upregulating 
transcription  of c-fos  and  c-jun  mRNA  indicates  a  pro- 
found action of PAF on gene activation in fibroblasts.  Our 
results are in agreement with recent studies demonstrating 
that PAF stimulates the expression of c-fos in human lym- 
phoblastoid cells (19) and mouse A-431 cells (22). 
Figure 5.  lntracellular signaling pathway in PAF-induced gene activa- 
tion  in  fibroblasts.  Effects  of signal  transduction  inhibitors  on  PAF- 
induced gene transcription by Northern blot analysis, mKNAs were iso- 
lated at the time points of maximal transcription: c-fos, 30 min; c-jun, 60 
min; IL-6 60 min; or IL-8, 4  h. The concentrations used were  (a) PAF, 
10 -8 M;  (b) WEB 2170 2  ￿  10 -s M;  (c) pertussis toxin,  100 ng/ml; (d) 
genistein,  100  I~g/ml;  (e)  polymyxin B,  10 raM.  The picture displays a 
characteristic time course in cell line L035; similar results were obtained 
with the other nine cell lines. 
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Figure 6.  Intracellular  signaling pathways  involved in  PAF  receptor 
mediated interleukin secretion. Effects of signal transduction inhibitors on 
PAF-induced secretion of IL-6 or IL-8 in cultivated transduction inhibi- 
tors, as described in legend to  Fig.  5.  In addition,  a second inhibitor of 
PKC, staurosporine (10 mM), was used. The amount of secreted interleu- 
kins was determined in 100 pJ of culture medium that was obtained from 
subconfluent cultures of pulmonary fibroblasts (105 cell) 20 h after the ad- 
dition of PAF. Each data point represents mean -+ SE of 10 independent 
experiments. Figure 7.  Mitogenic activity of PAF and its con- 
trol.  (a)  Dose dependency  of  PAF-induced 
[3H]thymidine incorporation by human lung fibro- 
blasts. (b) Inhibitory effects of various signal trans- 
duction inhibitors on PAF-induced de novo syn- 
thesis of DNA  in  cultivated human pulmonary 
fibroblasts. Fibroblasts were treated with the same 
concentrations of signal transduction inhibitors as 
described in legends to Figs. 5 and 6.  (c) Effect of 
neutralizing anti-PDGF-BB  and  anti-IL-6  anti- 
bodies on PAF-dependent [3H]thymidine  incorpo- 
ration.  The  incorporated [3H]thymidine by  pul- 
monary fibroblasts (105 cell) was  determined by 
liquid scintillation counting 24 h after the addition 
of PAF. 
Connective tissue  ceils  such as fibroblasts respond to cy- 
tokines  and  inflammatory  mediators,  including  PAY  (28, 
29, 48). We have demonstrated earlier that human lung fi- 
broblasts  are  capable  of producing  IL-6  after  stimulation 
with  the  three  PDGF  isoforms  (37).  Comparing  the  po- 
tency  of PDGF  isoforms  to  equimolar  concentrations  of 
PAY, one has to note that PAY exerts a lower potency on 
stimulating  the  expression  of the  IL-6 gene in  these  cells. 
The observation that PAF stimulates the expression of IL-6 
and IL-8 in cultivated human lung fibroblasts has some im- 
portant implications for PAY-mediated inflammatory mecha- 
nisms in the human lung.  IL-6 has been shown to induce a 
variety of proinflammatory  effects that are  relevant  to  in- 
flammation of the airways, including its ability to stimulate 
proliferation  of thymocytes and T  cells  (49,  50), to stimu- 
late cytotoxic T  lymphocyte differentiation  (51), to upreg- 
ulate IL-4--dependent IgE production (52),  and to mediate 
the  terminal  differentiation  and  Ig production  of B  cells 
(49).  The proinflammatory effects of IL-8 are  reflected by 
its ability to recruit neutrophils and eosinophils into inflam- 
matory sites  and to modulate the expression of various ad- 
hesion  molecules  in  bronchial  epithelial  cells  (53,  54)  and 
lung macrophages (55).  IL-8 also augments the production 
ofproteases by neutrophils  (56), generation of oxygen radi- 
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Our data obtained in vitro are consistent with the  clinical 
observation of elevated levels of IL-6 and IL-8 in the bron- 
choalveolar lavages and biopsies  of symptomatic asthmatic 
individuals  (59, 60). 
The finding that PAF stimulates the proliferation of cul- 
tivated human lung fibroblasts may reflect a key reaction of 
the cells to inflammatory mediators. It may contribute to the 
structural abnormalities found in asthmatic airways, namely 
to subepithelial fibrosis (30). Similar to the data obtained on 
PAF-induced  expression  of the  IL-6 gene,  the  efficacy of 
PAF on cell proliferation is about 5 to 10 times lower com- 
pared  to  equimolar  concentrations  of PDGF-BB  on  the 
same cell type (31, 32, 36, 37). However, the PAF-induced 
proliferation of human lung fibroblasts does not involve the 
secreted IL-6 or other mitogens such as PDGF as we have 
demonstrated by the use of neutralizing anti-IL-6 or anti- 
PDGF-BB  antibodies.  Preliminary  experiments  using  an 
antisense strategy to inhibit the expression ofc-fos, NF-K_B, 
or  IL-6  revealed  that  the  mitogenic  potency  of PAF  is 
abolished in the presence of effective concentrations of an- 
tisense  oligonucleotides  directed  against  c-fos,  NF-r,B,  or 
IL-6 mRNAs. Consistent with earlier studies on the mito- 
genic  action  of PDGF,  our observation indicates  that  the 
three  factors,  c-fos,  NF-KB,  and  IL-6,  are  essentially  in- 
volved in the PAF-induced cell cycle progression (37; our 
unpublished observation). 
In conclusion, PAF activation of human pulmonary fi- 
broblasts,  one of the most abundant cell types in the body, 
may amplify chronic inflammatory responses. We have dem- 
onstrated that human lung fibroblasts express functional PAF 
receptors that mediate PAF-induced transcription  of c-fos, 
IL-6, and IL-8 genes upon binding of PAF. The signaling 
cascade resulting  in transcription  of the  genes  involves  G 
proteins, tyrosine kinases, and PKC. In contrast, PAF-stim- 
ulated transcription  of c-jun requires pertussis toxin--sensi- 
tive  signaling pathways only. Thus,  PAF plays a profound 
role in affecting human lung fibroblast physiology. Our data 
also support a model for a network of communication be- 
tween  structural  tissue  and inflammatory cells  that  collec- 
tively function to mediate pulmonary inflammation such as 
bronchial asthma. 
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